Is there a common molecular pathway for addiction?
The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Abstract
Drugs of abuse have very different acute mechanisms of action but converge on the brain's reward pathways by producing a series of common functional effects after both acute and chronic administration. Some similar actions occur for natural rewards as well. Researchers are making progress in understanding the molecular and cellular basis of these common effects. A major goal for future research is to determine whether such common underpinnings of addiction can be exploited for the development of more effective treatments for a wide range of addictive disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, repeated substance use activates accumulating levels of ΔFosB, and animals with elevated ΔFosB exhibit exaggerated sensitivity to the rewarding effects of drugs of abuse, leading to the hypothesis that ΔFosB might be a sustained molecular trigger or switch that helps initiate and maintain a state of addiction.141,142”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [141]
In the citing paper
“Thus, dopamine release causes a pleasurable experience that is critical for reinforcing the effects of tobacco and nicotine dependence”
From Prenatal nicotine exposure during pregnancy results in adverse neurodevelopmental alterations and neurobehavioral deficits (2023) · cites this paper as [25]
In the citing paper
“There is evidence that all addictions, both drug-related and behavioral, result from a common mechanism in the brain [26].”
From Social Media Algorithms and Teen Addiction: Neurophysiological Impact and Ethical Considerations (2025) · cites this paper as [26]
In the citing paper
“Recent studies indicate that compulsive sexual arousal may be addictive and hazardous to otherwise healthy people because it has neurological effects on the brain that are comparable to those of drugs (Love et al., 2015;Nestler, 2005;Phillips et al., 2015;Reisman, 2004;Voon et al., 2014).”
From “Your Addiction, her Sexual Suffering”—A Qualitative Inquiry into the Effects of Compulsive Sexual Behaviors on Intimate Female Partners (2025) · cites this paper as Nestler, 2005
In the citing paper
“One of the most dramatic examples of protein expression induction is in the transcription factor ΔFosB, a Fos family protein, which accumulates in the NAc after chronic exposure to drugs of abuse, including alcohol, amphetamine, cannabinoids, cocaine, nicotine, opiates, and phencyclidine [86,87].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [86]
12 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Dopamine, learning and motivation.
Wise, R. A. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1406 · Cited by 3,379
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Molecular basis of long-term plasticity underlying addiction
Nestler, E. J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35053570 · Cited by 1,859
Self-citationRobinson, T. E., & Berridge, K. C. (2003) · Annual Review of Psychology · doi:10.1146/annurev.psych.54.101601.145237 · Cited by 1,509
CARLEZONJR, W., DUMAN, R., & NESTLER, E. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.06.005 · Cited by 1,346 · cited 1×
“Despite this opposite regulation of CREB in the NAc by different drugs, activation of CREB seems to produce similar behavioral effects: in numerous experimental systems, increased CREB activity in the NAc decreases behavioral responses to cocaine, opiates and alcohol, whereas decreased CREB activity increases such res…”
BackgroundSelf-citationAddiction and the brain: The neurobiology of compulsion and its persistence
Hyman, S. E., & Malenka, R. C. (2001) · Nature Reviews Neuroscience · doi:10.1038/35094560 · Cited by 1,302
Adaptive Coding of Reward Value by Dopamine Neurons
Tobler, P. N., Fiorillo, C. D., & Schultz, W. (2005) · Science · doi:10.1126/science.1105370 · Cited by 1,276 · cited 1×
“Growing evidence indicates that the VTA-NAc pathway and the other limbic regions cited above similarly mediate, at least in part, the acute positive emotional effects of natural rewards, such as food, sex and social interaction”
BackgroundDrugs of Abuse and Stress Trigger a Common Synaptic Adaptation in Dopamine Neurons
Saal, D., Dong, Y., Bonci, A., & Malenka, R. C. (2003) · Neuron · doi:10.1016/s0896-6273(03)00021-7 · Cited by 1,147 · cited 1×
“Numerous types of drugs of abuse, including cocaine, amphetamine, opiates, alcohol or nicotine, induce a long-term potentiation (LTP)-like state in VTA dopamine neuron”
The Neuroscience of Natural Rewards: Relevance to Addictive Drugs
Kelley, A. E., & Berridge, K. C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03306.2002 · Cited by 1,123 · cited 1×
“Growing evidence indicates that the VTA-NAc pathway and the other limbic regions cited above similarly mediate, at least in part, the acute positive emotional effects of natural rewards, such as food, sex and social interaction”
BackgroundStructural plasticity associated with exposure to drugs of abuse
Robinson, T. E., & Kolb, B. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.025 · Cited by 1,113 · cited 1×
“Chronic exposure to cocaine, amphetamine or nicotine causes long-lasting increases in dendritic arborization and in the density of dendritic spines of these neuron”
Background
Cited by
Items 701–800 of 1,001
Maternal responsivity and oxytocin in opioid‐dependent mothers
Daigle, K. M., Heller, N. A., Sulinski, E., Shim, J., Lindblad, W. J., Brown, M. S., Gosse, J. A., & Hayes, M. J. (2019) · Developmental Psychobiology · doi:10.1002/dev.21897 · Cited by 17
Design, Synthesis and Discovery of Picomolar Selective α4β2 Nicotinic Acetylcholine Receptor Ligands
Yenugonda, V. M., Xiao, Y., Levin, E. D., Rezvani, A. H., Tran, T. P., Al‐Muhtasib, N., Sahibzada, N., Xie, T., Wells, C., Slade, S. K., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4008455 · Cited by 18
Salas, E., Bocos, C., del Castillo, C., Pérez‐García, C., Morales, L., & Alguacil, L. F. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.06.034 · Cited by 17
Belin, D., & Everitt, B. J. (2010) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-374767-9.00033-0 · Cited by 19
Altered nociception and morphine tolerance in neuropeptide FF receptor type 2 over‐expressing mice
Lin, Y., Kao, S. C., Day, Y., Chang, C. C., & Chen, J. (2015) · European Journal of Pain · doi:10.1002/ejp.814 · Cited by 17
“Nevertheless, overexpression of NPFFR2 did not modify the degree of behavioural sensitization to morphine or morphineCPP, indicating that NPFFR2 might not associate with brain mesolimbic dopamine reward pathway (Nestler, 2005).”
BackgroundThe mesolimbic system and eating addiction: what sugar does and does not do
de Jong, J. W., Vanderschuren, L. J. M. J., & Adan, R. A. H. (2016) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2016.03.004 · Cited by 21
“There is strong evidence that plasticity changes in this system facilitate the development of addictive behavior [21,22].”
López‐Moreno, J. A., González‐Cuevas, G., & Navarro, M. A. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.09.010 · Cited by 17
“Therefore, in this study, the proposed final common molecular pathway for the reinforcing effects of the abused drugs (Nestler, 2005; Pierce and Kumaresan, 2005) could be compromised in some way.”
Microarray analysis identifies cerebellar genes sensitive to chronic ethanol treatment in PKCγ mice
Bowers, B. J., Radcliffe, R. A., Smith, A. M., Miyamoto-Ditmon, J., & Wehner, J. M. (2006) · Alcohol · doi:10.1016/j.alcohol.2006.09.004 · Cited by 17
“These genes were selected based on their possible significance in the neurobiology of addiction (Janak et al., 2006;Nakahara et al., 2002;Nestler, 2001,2005).”
BackgroundCircular RNA regulation and function in drug seeking phenotypes
Daws, S. E., & Gillespie, A. (2023) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2023.103841 · Cited by 16
Bormann, N. L., Oesterle, T., Arndt, S. V., Karpyak, V. M., & Croarkin, P. E. (2024) · American Journal on Addictions · doi:10.1111/ajad.13517 · Cited by 16
The distribution of neurotransmitters in the brain circuitry: Mesolimbic pathway and addiction
Ebrahimi, M. N., Banazadeh, M., Alitaneh, Z., suha, A. J., Esmaeili, A., Hasannejad-Asl, B., Siahposht-Khachaki, A., Hassanshahi, A., & Bagheri‐Mohammadi, S. (2024) · Physiology & Behavior · doi:10.1016/j.physbeh.2024.114639 · Cited by 19
Ostergren, J. E., Dingel, M. J., McCormick, J. B., & Koenig, B. A. (2015) · Journal of Health Communication · doi:10.1080/10810730.2014.999895 · Cited by 16
“Prominent biological theories of addiction implicate the brain reward system: the genes, neurotransmitters, transporters, and enzyme targets of the dopamine, serotonin, and glutamate systems of the brain (C.-S. R. Li & Sinha, 2008; Nestler, 2005; Schnoll, Johnson, & Lerman, 2007).”
BackgroundWang, Y., Yan, K.-J., Fan, C.-X., Luo, X.-N., & Zhou, Y. (2019) · BMC Neuroscience · doi:10.1186/s12868-019-0548-y · Cited by 16
Long‐term safety and efficacy of nalmefene in Japanese patients with alcohol dependence
Higuchi, S., Takahashi, M., Murai, Y., Tsuneyoshi, K., Nakamura, I., Meulien, D., & Miyata, H. (2020) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13017 · Cited by 16
“This may be attributed to the pharmacological activity of nalmefene as an opioid antagonist of the μ and δ receptors and a partial agonist of the κ receptor, which do not activate the reward circuits in the brain associated with dependence.(18) In the lead-in study conducted as a randomized controlled trial, compared…”
BackgroundTemporal Dynamics of Large-Scale Networks Predict Neural Cue Reactivity and Cue-Induced Craving
Wang, K. S., Kaiser, R. H., Peechatka, A. L., Frederick, B. B., & Janes, A. C. (2020) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2020.07.006 · Cited by 19
Early life stress and susceptibility to addiction in adolescence
Tschetter, K. E., Callahan, L. B., Flynn, S., Rahman, S., Beresford, T. P., & Ronan, P. J. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2021.08.007 · Cited by 18
Ashare, R. L., Wileyto, E. P., Ruparel, K., Goelz, P. M., Hopson, R. D., Valdez, J. N., Gur, R. C., Loughead, J., & Lerman, C. E. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.09.003 · Cited by 18
“Dopamine evels in prefrontal cortex (PFC), regulated in part by the catechol-methyltransferase (COMT) enzyme, play a role in cognitive unction and nicotine dependence (Goldberg and Weinberger, 004; Nestler, 2005).”
BackgroundCommon genes regulate food and ethanol intake in Drosophila
Sekhon, M. L., Lamina, O., Hogan, K. E., & Kliethermes, C. L. (2016) · Alcohol · doi:10.1016/j.alcohol.2016.04.001 · Cited by 16
Tipps, M. E., & Buck, K. J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.05.012 · Cited by 19
Fabbricatore, A. T., Ghitza, U. E., Prokopenko, V. F., & West, M. O. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07230.x · Cited by 18
“structure of the NAcc, the ventral pallidum, has been described as a common neurophysiological event in the administration of most, if not all, drugs of abuse (Wise, 2002; Nestler, 2005).”
Upregulation of β‐Catenin Levels in Superior Frontal Cortex of Chronic Alcoholics
Alhousseini, A., Sivanandam, T. M., Bradbury, E. L., Tannenberg, R. K., Dodd, P. R., & Gu, Q. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00670.x · Cited by 18
Yin, L., Li, F., Li, J., Yang, X., Xie, X., Xue, L., Li, Y., & Zhang, C. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02783-8 · Cited by 17
Maurya, M. R., & Subramaniam, S. (2007) · Biophysical Journal · doi:10.1529/biophysj.106.097501 · Cited by 16
Higuchi, M., Suzuki, Y., Yatani, Y., Kitagawa, Y., Nagayasu, K., Shirakawa, H., Nakagawa, T., & Kaneko, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05583.x · Cited by 16
A conceptual framework for the intersection of hyperalgesia and hyperkatifeia in alcohol addiction
Koob, G. F., & Vendruscolo, L. F. (2025) · Alcohol · doi:10.1016/j.alcohol.2025.08.004 · Cited by 17
Fernández‐Espejo, E., Ramiro-Fuentes, S., & de Fonseca, F. R. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.023 · Cited by 16
Transcranial Magnetic Stimulation as an Interventional Tool for Addiction
Steele, V. R. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.592343 · Cited by 15
“Drug use increases DA release in MCL-DA system (Jay, 2003; Kelley, 2004; Nestler, 2005), which is thought to be an important element in learning, goal-directed behavior, and reward processing (Everitt and Robbins, 2005; Kalivas and O’Brien, 2008).”
BackgroundOxytocin Attenuates Expression, but Not Acquisition, of Sucrose Conditioned Place Preference in Rats
Patel, D., Sundar, M., Lorenz, E., & Leong, K.-C. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.603232 · Cited by 15
“These differences might be due to natural and drug reward being mediated by overlapping yet distinct neural pathways (Nestler, 2005; Alhadeff et al., 2019), resulting in a differential effect of oxytocin at various stages of rewardseeking behaviors.”
BackgroundGenetic architecture of four smoking behaviors using partitioned SNP heritability
Evans, L. M., Jang, S.-K., Hancock, D. B., Ehringer, M. A., Otto, J. M., Vrieze, S. I., & Keller, M. C. (2021) · Addiction · doi:10.1111/add.15450 · Cited by 17
Strategies for cellular deconvolution in human brain RNA sequencing data
Sosina, O. A., Tran, M. N., Maynard, K. R., Tao, R., Taub, M. A., Martinowich, K., Semick, S. A., Quach, B. C., Weinberger, D. R., Hyde, T. M., et al. (2021) · F1000Research · doi:10.12688/f1000research.50858.1 · Cited by 15
Greener, M.-R., & Storr, S. J. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1166852 · Cited by 15
“The result of hyperactive CRF-containing neurons in the amygdala is recruitment of the hypothalamic–pituitary–adrenal axis and brain stress systems (Nestler, 2005).”
BackgroundThioredoxin-1 expression regulated by morphine in SH-SY5Y cells
Luo, F., Feng, Y., Zhao, L., Li, K., Wang, S., Song, J., & Bai, J. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.06.039 · Cited by 15
Zill, P., Vielsmeier, V., Büttner, A., Eisenmenger, W., Siedler, F., Scheffer, B., Möller, H. ‐., & Bondy, B. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0129-7 · Cited by 15
Kurokawa, K., Mizuno, K., Shibasaki, M., & Ohkuma, S. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11106fp · Cited by 15
Platt, D. M., & Bano, K. M. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.09.064 · Cited by 15
“…mechanisms, including the ventral tegmental area and nucleus accumbens; and stimulation of these neurons by their respective endogenous ligands can result in increases in dopamine release, an important mechanism underlying reinforcement processes (Jamensky and Gianoulakis, 1999; Nestler, 2005).”
BackgroundNicotine-induced enhancement of Pavlovian alcohol-seeking behavior in rats
Maddux, J.-M. N., & Chaudhri, N. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4508-2 · Cited by 15
Hildebrandt, B. A., Sinclair, E. B., Sisk, C. L., & Klump, K. L. (2018) · International Journal of Eating Disorders · doi:10.1002/eat.22895 · Cited by 15
“…of the reward system (i.e., hyporesponsivity) and more frequent and/or severe BE to achieve the same rewarding response experienced in earlier stages (a pattern observed for drugs/alcohol - see Boileau et al., 2003; Dawe, Gullo, & Loxton, 2004; Nestler, 2005; Willner, James, & Morgan, 2005).”
Koshimizu, H., Matsuoka, H., Nakajima, Y., Kawai, A., Ono, J., Ohta, K., Miki, T., Sunagawa, M., Adachi, N., & Suzuki, S. (2021) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12208 · Cited by 16
Morphine-conditioned cue alters c-Fos protein expression in the brain of crayfish
Dziopa, L., Imeh‐Nathaniel, A., Baier, D., Kiel, M. C., Sameera, S., Brager, A., Beatriz, V., & Nathaniel, T. I. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.04.003 · Cited by 16
Han, M., & Friedman, A. K. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.09.009 · Cited by 15
“There is an accumulating body of evidence supporting the idea that some psychiatric disorders such as drug addiction, depression and bipolar disorder or different addictive drugs interact with overlapping brain mechanisms, and even share the samemolecular pathways or neural circuits (Nestler, 2005; Roybal et al., 2007…”
BackgroundOuachikh, O., Dieb, W., Durif, F., & Hafidi, A. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.12.021 · Cited by 16
Activators of G-protein signaling 3: a drug addiction molecular gateway
Bowers, M. S. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833dcfa5 · Cited by 17
“…and Robinson, 1998; Berke and Hyman, 2000; Jay, 2003) and can also change the gene expression and function (Berke and Hyman, 2000; Canales, 2005; Nestler, 2005) of circuitry that normally processes motivationally relevant environmental stimuli and adaptive goal-directed responding (Koob et al.,…”
InfluentialJacobsen, J. H. W., Buisman‐Pijlman, F. T. A., Mustafa, S., Rice, K. C., & Hutchinson, M. R. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.08.021 · Cited by 16
Dopamine dysregulation syndrome in Parkinson's disease patients: From reward to penalty
Bonci, A., & Singh, V. (2006) · Annals of Neurology · doi:10.1002/ana.20878 · Cited by 15
Schochet, T. L., Bremer, Q. Z., Brownfield, M. S., Kelley, A. E., & Landry, C. F. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06483.x · Cited by 14
“The remodeling of synaptic connections, a fundamental process underlying learning and behavioral adaptation, is strongly influenced by addictive drugs like nicotine (Robinson & Kolb, 2004; McDonald et al., 2005; Nestler, 2005).”
BackgroundKurdyś, P., Kośmider, L., Bykowski, W., Konwant, D., & Stencel‐Gabriel, K. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21111493 · Cited by 14
STRECK, E. L., Prá, S. D.-T. D., Ferro, P. R., Carvalho‐Silva, M., Gomes, L. M., Agostini, J. F., Damiani, A. P., de Andrade, V. M., Schuck, P. F., Ferreira, G. C., et al. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3070-5 · Cited by 14
Benedetto, M. D., Candia, S. B., D’Addario, C., Porticella, E. E., Cavina, C., Candeletti, S., & Romualdi, P. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0587-5 · Cited by 18
“1997) and that CREB may influence rewarding mechanisms through different target genes, including the pDYN and the pN/OFQ one (Carlezon et al. 2005; Nestler 2005; Rosenberger et al. 2001).”
BackgroundFlores, J. A., Galán-Rodríguez, B., Rojo, A. I., Ramiro-Fuentes, S., Cuadrado, A., & Fernández‐Espejo, E. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.10.009 · Cited by 14
Reid, R. C., Carpenter, B. N., & FONG, T. W. (2011) · Surgical Neurology International · doi:10.4103/2152-7806.81427 · Cited by 15
Addiction: Informing drug abuse interventions with brain networks
Steele, V. R., Ding, X., & Ross, T. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813838-0.00006-6 · Cited by 21
Acute Atomoxetine Selectively Modulates Encoding of Reward Value in Ventral Medial Prefrontal Cortex
Suzuki, C., Ikeda, Y., Tateno, A., Okubo, Y., Fukayama, H., & Suzuki, H. (2019) · Journal of Nippon Medical School · doi:10.1272/jnms.jnms.2019_86-205 · Cited by 14
Activation of trace amine‐associated receptor 1 attenuates nicotine withdrawal‐related effects
Wu, R., Liu, J., Johnson, B., Huang, Y., Zhang, Y., & Li, J. (2021) · Addiction Biology · doi:10.1111/adb.13075 · Cited by 15
Jia, M., Wang, X., Zhang, H., Wang, X., Ma, H., Yang, M., Li, Y., & Cui, C. (2021) · Addiction Biology · doi:10.1111/adb.13086 · Cited by 14
Inozemtseva, O., Pérez-Solís, L., Matute, E., & Juárez, J. (2016) · Substance Use & Misuse · doi:10.1080/10826084.2016.1178293 · Cited by 16
“…executive impairment is associated with affectations of the central nervous system (CNS) (Matochik, London, Eldreth, Cadet & Bolla, 2003; Adinoff, et al., 2003; Volkow et al., 1993) at the functional, macrostructural, cellular, and molecular levels (Nestler, 2005; Koob, Sanna & Boom, 1998).”
BackgroundKoob, G. F., Kandel, D. B., Baler, R. D., & Volkow, N. D. (2015) · Psychiatry · doi:10.1002/9781118753378.ch22 · Cited by 13
Addiction Circuitry in the Human Brain
Volkow, N. D., Wang, G., Fowler, J. S., & Tomasi, D. G. (2015) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.130306 · Cited by 17
Pharmacogenetics and Smoking Cessation with Nicotine Replacement Therapy
Ray, R., Schnoll, R. A., & Lerman, C. E. (2007) · CNS Drugs · doi:10.2165/00023210-200721070-00001 · Cited by 14
Liu, E., Pang, K., Liu, M., Tan, X., Hang, Z., Mu, S., Han, W., Yue, Q., Comai, S., & Sun, J. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02218-5 · Cited by 13
“Importantly, these drugs induce long-term changes in DA levels and DA neuron excitability within the mesocorticolimbic DA system [5 – 7].”
Canfield, J. R., & Sprague, J. E. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03887-z · Cited by 13
McDevitt, D. S., & Graziane, N. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.08.025 · Cited by 14
Kohlmeier, K. A., & Polli, F. S. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.00003 · Cited by 14
“Drugs of abuse exhibit a variety of pharmacological mechanisms, and rises in DA can occur via actions in the synaptic cleft, direct excitation of DA cells, and/or via activation of non-DA VTA cells (Nestler, 2005; Lüscher and Ungless, 2006; Pierce and Kumaresan, 2006).”
BackgroundChang, X., Sun, Y., Muhai, J., Li, Y., Chen, Y., Lü, L., Chang, S., & Shi, J. (2022) · Addiction · doi:10.1111/add.15908 · Cited by 13
Rossato, D. R., Rosa, H. Z., da Rosa, J. L. O., Milanesi, L. H., Metz, V. G., D’avila, L. F., & Bürger, M. E. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02927-y · Cited by 14
“The transcription factor ΔFosB (35–37 kDa) was investigated because it is involved in the effects of natural and drug rewards, whose effects supposedly contribute to neuroadaptations in DA-regulated signaling [60, 61].”
BackgroundImpact of baseline prepulse inhibition on nicotine-induced locomotor sensitization in rats
Kayır, H., Göktalay, G., Yavuz, O., & Uzbay, T. I. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.08.004 · Cited by 14
Leão, R. M., Cruz, F. C., de Oliveira, P. E. C., Rossetto, D. D. B., Valentini, S. R., Zanelli, C. F., & Planeta, C. S. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.01.007 · Cited by 13
“The panel was equipped with two levers, located 5 cm from the floor, two cue lights (red and green) above each lever and a session light in the middle of the panel (12 cm from the floor).”
MethodKurokawa, K., Mizuno, K., Shibasaki, M., & Ohkuma, S. (2011) · Synapse · doi:10.1002/syn.20997 · Cited by 13
“One of major brain reward circuitry implicated in the development and expression of addictive behaviors is the mesolimbic dopamine pathway, which comprises the ventral tegmental area with its dopaminergic projection to the nucleus accumbens and medial prefrontal cortex (Nestler, 2005).”
BackgroundA way to overcome addiction, the modern dungeon
Heon, K. K. (2007) · Korean Journal of Health Psychology · doi:10.17315/kjhp.2007.12.4.001 · Cited by 14
Decoding the transcriptional programs activated by psychotropic drugs in the brain
Zygmunt, M., Piechota, M., Parkitna, J. M. R., & Korostyński, M. (2018) · Genes Brain & Behavior · doi:10.1111/gbb.12511 · Cited by 13
“For example, despite different molecular targets, drugs of abuse largely converge their actions on the dopamine system and show significant overlap in associated gene expression patterns.(68,124)”
BackgroundGazan, A., Rial, D., & Schiffmann, S. N. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14581 · Cited by 13
“The striatum is the major entry to the basal ganglia circuitry and is functionally subdivided into dorsal striatum or caudate‐putamen (CPu), which controls motor behaviour and motor learning, and the ventral striatum including the nucleus accumbens (NAc), responsible for the regulation of motivational processes (Barbe…”
BackgroundDomi, E., Xu, L. X., Pätz, M., Nordeman, A., Augier, G., Holm, L., Toivainen, S., Augier, E., Hansson, A. C., & Heilig, M. A. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15210 · Cited by 13
“Both alcohol and nicotine influence the activity of dopamine VTA neurons (Nestler, 2005).”
BackgroundInguscio, B. M. S., Cartocci, G., Modica, E., Rossi, D., Martinez-Levy, A. C., Cherubino, P., Tamborra, L., & Babiloni, F. (2021) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2021.06.010 · Cited by 15
ΔFosB in the supraoptic nucleus contributes to hyponatremia in rats with cirrhosis
Cunningham, J. T., Nedungadi, T. P., Walch, J. D., Nestler, E. J., & Gottlieb, H. B. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00142.2012 · Cited by 14
Self-citationA “Neuropsychoanalytic” Treatment of a Patient with Cocaine Dependence
Johnson, B. (2009) · Neuropsychoanalysis · doi:10.1080/15294145.2009.10773612 · Cited by 13
“The brains of these patients have been changed forever by exposure to chemicals that alter the alignment of ventral tegmental/dopamine–glutamate/nucleus accumbens/hippocampal–amygdalar–cingulate–frontal functioning (Di Chiara & Bassareo, 2007; Kalivas, 2007; Kalivas & Volkow, 2005; Kalivas, Volkow, & Seamans, 2005; Ke…”
BackgroundAcute and Chronic Effects of Betel Quid Chewing on Brain Functional Connectivity
Sariah, A., Guo, S., Zuo, J., Pu, W., Liu, H., Rolls, E. T., Xue, Z., Liu, Z., & Huang, X. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00198 · Cited by 14
“Exclusion criteria included: (1) a history of neurological disorder or other serious physical illness; (2) a history of any mental disorders; (3) a history of substance abuse other than BQ; (4) a contraindication to MRI.”
BackgroundSuman, A., Mehta, B., Guo, M., Chu, X., Fibuch, E. E., Mao, L., & Wang, J. Q. (2010) · Neuroscience Research · doi:10.1016/j.neures.2010.06.001 · Cited by 13
Shibasaki, M., Katsura, M., Kurokawa, K., Torigoe, F., & Ohkuma, S. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0070885 · Cited by 13
Maldonado, M., Molfese, D. L., Viswanath, H., Curtis, K. N., Jones, A., Hayes, T. G., Marcelli, M., Mediwala, S. N., Baldwin, P. R., Garcia, J. M., et al. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12286 · Cited by 13
The role of ghrelin/GHS-R1A signaling in nonalcohol drug addictions
Sustkova-Fiserova, M., Charalambous, C., Khryakova, A., Certilina, A., Lapka, M., & Šlamberová, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020761 · Cited by 12
Impacts of Sexual Addiction on Intimate Female Partners—The State of the Art
Seyed Aghamiri, F., Luetz, J. M., & Hills, K. (2022) · Sexual Health & Compulsivity · doi:10.1080/26929953.2022.2050862 · Cited by 12
“According to a large number of recent studies, there is a consensus that SA/CSB indicates that compulsive sexual arousal, unlike healthy sexual behaviors, impacts the nervous system like a drug and, like many drugs, may be addictive and dangerous to otherwise healthy individuals (Love, Laier, Brand, Hatch, & Hajela, 2…”
BackgroundSylvestre, M.-P., Chagnon, M., Wellman, R. J., Dugas, E. N., & O’Loughlin, J. (2018) · American Journal of Epidemiology · doi:10.1093/aje/kwy045 · Cited by 12
“Dopamine controls the reward pathway and, thus, is a major contributor to the development of addiction (35).”
BackgroundFrom “Oh, OK” to “Ah, yes” to “Aha!”: Hyper-systemizing and the rewards of insight
Fields, C. (2011) · Personality and Individual Differences · doi:10.1016/j.paid.2011.02.010 · Cited by 15
“…has been replaced by an integrated-systems concept that emphasizes reward-related learning, and in particular unconscious increases in salience of reward-related stimuli (Kelley and Berridge, 2002; Hyman, 2005; Nestler, 2005; Hyman et al ., 2006; Grace et al. , 2007; Robinson and Berridge, 2008).”
BackgroundFerreira, G. K., Carvalho‐Silva, M., Gomes, L. M., Scaini, G., Teixeira, L. J., Mota, I. T., Schuck, P. F., Ferreira, G. C., & STRECK, E. L. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9615-3 · Cited by 12
The Media and Behavioral Genetics: Alternatives Coexisting with Addiction Genetics
Dingel, M. J., Ostergren, J. E., McCormick, J. B., Hammer, R. R., & Koenig, B. A. (2014) · Science Technology & Human Values · doi:10.1177/0162243914558491 · Cited by 12
van Duijvenbode, N., Didden, R., Korzilius, H. P. L. M., & Engels, R. C. M. E. (2016) · Advances in Neurodevelopmental Disorders · doi:10.1007/s41252-016-0005-1 · Cited by 13
“…The Netherlands 6 Pluryn, P.O. Box 53, 6500 AB Nijmegen, The Netherlands Problematic substance use has been associated with disruptions in the motivational, reward and inhibitory control processes and subsequent deficiencies in information processing (Koob 2013; Hyman et al. 2006; Nestler 2005).”
BackgroundThe incentive amplifying effects of nicotine: Roles in alcohol seeking and consumption
King, C. P., & Meyer, P. (2022) · Advances in pharmacology · doi:10.1016/bs.apha.2021.10.008 · Cited by 12
Grundinger, N., Gerhardt, S., Karl, D., Mann, K. F., Kiefer, F., & Vollstädt‐Klein, S. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06137-1 · Cited by 14
“Our findings underpin the use of nalmefene to reduce alcohol consumption when confronted with alcohol-associated stimuli and are consistent with reward centered addiction models (Nestler 2005; Koob and Volkow 2010).”
MethodGao, R., Schneider, A. M., Mulloy, S., & Lee, A. M. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.16109 · Cited by 14
“The VTA is critically important for natural and drug reward processing and is cellularly heterogenous, with dopaminergic, GABAergic and glutamatergic neurons and neurons that co-express two neurotransmitters (Morales & Margolis, 2017; Nestler, 2005; Trudeau et al., 2014).”
The influence of drug class on reward in substance use disorders
Jones, J. D., Arout, C. A., Luba, R. R., Murugesan, D., Madera, G., Gorsuch, L., Schusterman, R., & Martinez, S. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173771 · Cited by 12
Engineering endomorphin drugs: state of the art
Lazarus, L. H., & Okada, Y. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.646261 · Cited by 13
“This physiological assessment of the action of EM-2 fully supports the involvement of MOR agonists in homeostatic mechanisms [31,34].”
BackgroundLocomotor stimulation by acute propofol administration in rats: Role of the nitrergic system
Tezcan, A. H., Özçetin, A., Özlü, O., Çevreli, B., & Uzbay, T. I. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.03.003 · Cited by 12
Modulation of Mood States as a Major Factor in Relapse to Substance Use
Yadid, G., Redlus, L., Barnea, R., & Doron, R. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00081 · Cited by 12
“A plethora of gene changes develop in the brain during chronic use or abstinence, which are related to the glutamate/ corticoids, CREB/ERK, and NfκB pathways (Nestler, 2005; Li et al., 2008).”
BackgroundMore than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder
Moerke, M. J., McMahon, L. R., & Wilkerson, J. L. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018028 · Cited by 14
“This more gradual increase in nicotine concentration results in lower relative abuse liability, as slower absorption produces modest increases of dopamine over time in key areas of the brain related to substance use disorders in contrast to the corresponding quick spike of dopamine release and subsequent downstream si…”
BackgroundStroke, Smoking and Vaping: The No-Good, the Bad and the Ugly.
Klein, A. P., Yarbrough, K. L., & Cole, J. W. (2021) · PubMed · Cited by 14
Trace amine-associated receptor 1 and drug abuse
Wu, R., Liu, J., & Li, J. (2022) · Advances in pharmacology · doi:10.1016/bs.apha.2021.10.005 · Cited by 12
Hirasawa-Fujita, M., Bly, M. J., Ellingrod, V. L., Dalack, G. W., & Domino, E. F. (2014) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.mhmb.061314 · Cited by 13
“Opioid receptor activation inhibits GABAergic interneurons (inhibition of inhibition) to increase DA release in the ventral tegmental area (VTA) [63].”
BackgroundNagayasu, K., Kitaichi, M., Shirakawa, H., Nakagawa, T., & Kaneko, S. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.10075sc · Cited by 12
Comparison of Gene Expression Profile in Embryonic Mesencephalon and Neuronal Primary Cultures
Greco, D., Volpicelli, F., Lieto, A. D., Leo, D., Perrone‐Capano, C., Auvinen, P., & di Porzio, U. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004977 · Cited by 15
“Instead, alterations in VTA outputs are involved in schizophrenia[4], depression [5], attention deficit hyperactive disorder [6] and addiction [7].”
Alternative splicing in addiction
Bhatnagar, A., & Heller, E. A. (2025) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2025.102340 · Cited by 11
“Opioids can also directly act on NAc neurons by stimulating mu opioid receptors (MORs), further boosting dopamine transmission in NAc [11].”
InfluentialSachs, B. D., & Akassoglou, K. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351273 · Cited by 13
Metadata
- Authors
- Nestler, E. J.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Nestler, Eric J
- ORCID
- Nestler, Eric J
- Venue
- Nature Neuroscience
- Published
- 2005-10-26
- Volume
- 8
- Issue
- 11
- Pages
- 1445-1449
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W1988182239
- Cited by
- 1,388
- References
- 53
- Citations by year
- 2026: 22 · 2025: 47 · 2024: 54 · 2023: 57 · 2022: 49 · 2021: 56 · 2020: 62 · 2019: 70 · 2018: 61 · 2017: 66 · 2016: 72 · 2015: 81 · 2014: 86 · 2013: 94 · 2012: 79
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Social Sciences › Psychology › Clinical Psychology › Gambling Behavior and Treatments
- Keywords
- addiction, drugs of abuse, brain reward system, chronic drug administration, acute drug effects, natural reward, addiction treatment
- MeSH terms
- Animals, Humans, Models, Neurological, Nerve Net, Reward, Behavior, Addictive, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.